InMode rises after issuing guidance above consensus
Share- Nishadil
- January 16, 2024
- 0 Comments
- 1 minutes read
- 29 Views
Ralf Hahn InMode ( NASDAQ: INMD ) rose ~3% Tuesday pre market after the medical technologies company issued guidance above consensus. Q4 revenue is expected to be in the range of $126.0M to $126.5M, vs. consensus of $123.42M. 2023 revenue is estimated to be between $491.3M and $491.8M, vs. consensus of $488.71M.
Q4 non GAAP EPS should be in the range of $0.68 to $0.69, vs. consensus of $0.61. 2023 EPS should come between $2.54 to $2.55, vs. consensus of $2.47. 2023 non GAAP gross margin should be in the range of 83% to 85%. 2024 revenue is estimated to be in the range of $495M to $505M, below consensus of $519.84M.
InMode is set to hold a conference call to discuss its Q4 financial results on Feb. 13. Source: Press Release More on InMode InMode: Despite Attractive Valuation, I Believe It's Premature To Dive In Here's Why InMode Is Inherently Undervalued Bullish Support Observed InMode: A Deep Analysis Into Its Mixed Picture Inmode stock slides after macro conditions weigh on annual outlook UBS cuts InMode to neutral, says macro factors clouding visibility.
Disclaimer: This article was generated in part using artificial intelligence and may contain errors or omissions. The content is provided for informational purposes only and does not constitute professional advice. We makes no representations or warranties regarding its accuracy, completeness, or reliability. Readers are advised to verify the information independently before relying on
